Peer Reviewed Publications
2025 - 2024 - 2023 - 2022 - 2021 - 2020
2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011
2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004
2025
Orbital reactive lymphoid hyperplasia: Case series and literature review
Ajanaku A, Fenech M, Ghadiri N, Coupland SE
European Journal of Ophthalmology
2025
Understanding and Exacerbating the Biological Response of Uveal Melanoma to Proton Beam Therapy
Lin H., Kacperek A., Afshar RN., Heimann H., Coupland SE., Parkinson JL.
Cancers
DOI: 10.3390/cancers17193104
PMID: 41097633
2025
Monosomy 3 Prediction by Clinical Features and BAP1 Staining and Its Value When Integrated in Liverpool Uveal Melanoma Prognosticator Online (LUMPO3)
Czarnecki HD., Edwards A., Kalirai H., Afshar RN., Damato BE., Heimann H., Coupland SE.
Investigative Ophthalmology & Visual Science
DOI: 10.1167/iovs.66.13.17
PMID: 41065484
2025
How Many Patients with Choroidal Melanoma Would Be Eligible for Neoadjuvant Systemic Therapy to Enable Ruthenium-106 Brachytherapy?
Damato B., Edwards A., Coupland SE., Kalirai H., Heimann H.
Cancers
DOI: 10.3390/cancers17183022
PMID: 41008864
2025
Uveal Melanoma UK national guidelines: 2023 update
Coupland TJ., Bacon J., Coupland SE., Damato B., Errington H., Foss S., Kemp L., Kiilgaard T., Lotery R., Nathan P., Milford S., Natarajan G., Roberts S., Salvi JJ., Sagoo H., Seddon K., Salvi R., Tutt S., Taylor N., Wilson A., Weerasinghe M.
European Journal of Cancer
DOI: 10.1016/j.ejca.2025.115687
PMID: 40885127
